Cubist Systematic Strategies, LLC Burning Rock Biotech LTD Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.39 - $3.96 $104,531 - $173,198	-43,737 Reduced 60.93%	28,050 $67,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $125,627 - $749,456	71,787 New	71,787 $209,000
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $553,600 - $845,274	-82,627 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $779,172 - $1.42 Million	82,627 New	82,627 $787,000
Q3 2021 Nov 15, 2021	SELL	$17.37 - $27.92 $187,179 - $300,865	-10,776 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.14 - $37.45 $281,684 - $403,561	10,776 New	10,776 $317,000
Q3 2020 Nov 16, 2020	SELL	$19.07 - $29.61 $7,723 - $11,992	-405 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$23.21 - $31.43 $9,400 - $12,729	405 New	405 $11,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $716M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.